InsidersTradesSigma
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
4
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Matzen Dana, Vice-Président du Développement Commercial. Officer active across 1 company, notably IntelGenx Technologies Corp.. In total, 4 disclosures have been recorded. Breakdown: 4 buys · 0 sell. Total volume traded: €17k. History available since 8 June 2021. The latest transaction was disclosed on 21 September 2022 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Declarations4 total
25,000 shares@ US$0.13820.2% of flowCommon Stock, 0.00001 p.V.SEC:0001062993-22-019838:0
Ideal exit: 18 Jun 2023 (T+270)
25,000 shares@ US$0.26542.9% of flowCommon Stock, 0.00001 p.V.SEC:0001062993-22-009098:0
Ideal exit: 25 Dec 2022 (T+270)
10,000 shares@ US$0.4822.8% of flowCommon Stock, 0.00001 p.V.SEC:0001062993-21-005546
Ideal exit: 5 Mar 2022 (T+270)
10,000 shares@ US$0.4828.5% of flowCommon Stock, 0.00001 p.V.SEC:0001062993-21-005546:0
Ideal exit: 5 Mar 2022 (T+270)
4 of 4 declarations
About Matzen Dana
Dana Matzen is the VP of Business Development and Corporate Development of a subsidiary at IntelGenx Technologies Corp. She is responsible for the development strategy and growth of the company. Her role is essential in ensuring innovation and competitiveness for IntelGenx in the pharmaceutical technology sector.
